The Personalized Parkinson Project De Novo Cohort

Active, not recruitingOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

August 29, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Parkinson DiseaseParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersNeurodegenerative Diseases
Interventions
DEVICE

Verily Study Watch

Participants wear the Verily Study Watch for 2 years, for longitudinal data collection.

Trial Locations (1)

6500 HB

Radboud University Medical Center, Nijmegen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

collaborator

Verily Life Sciences LLC

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT04985539 - The Personalized Parkinson Project De Novo Cohort | Biotech Hunter | Biotech Hunter